#

Novo Nordisk

: 101
Structure shares double after near-homerun obesity pill data
Small Caps·
Structure shares double after 'near-homerun' obesity pill data
Highlights of the week: Apple rushes to the top, Google, Meta and Burry challenge Nvidia
Review·
Highlights of the week: Apple rushes to the top, Google, Meta and Burry challenge Nvidia
Morning in New York: trading will be held in hibernation mode
News·
Morning in New York: trading will be held in hibernation mode
Morning in New York: buyers are back in the majority
News·
Morning in New York: buyers are back in the majority
Novo will cut the price of Ozempic by 71% for older Americans. This will hinder revenue growth
News·
Novo will cut the price of Ozempic by 71% for older Americans. This will hinder revenue growth
A new drug from the creator of Ozempic has helped people lose weight. Is it time to buy stocks?
News·
A new drug from the creator of Ozempic has helped people lose weight. Is it time to buy stocks?
Morning in New York: macro statistics will set the trading vector
News·
Morning in New York: macro statistics will set the trading vector
Ozempics failed Alzheimers trial collapses Novo shares to lowest since 2021
News·
Ozempic's failed Alzheimer's trial collapses Novo shares to lowest since 2021
Eli Lilly became the first pharma giant to be capitalized at $1 trillion. Whats next?
News·
Eli Lilly became the first pharma giant to be capitalized at $1 trillion. What's next?
LifeMD stock down 25% as worsening outlook overshadows Novo Nordisk partnership news
Small Caps·
LifeMD stock down 25% as worsening outlook overshadows Novo Nordisk partnership news
Novo has lowered prices for obesity drugs in the US. This is a new challenge for Eli Lilly
News·
Novo has lowered prices for obesity drugs in the US. This is a new challenge for Eli Lilly
In Europe, investors are leaving the AI sector for healthcare. Which stocks are on the upside?
News·
In Europe, investors are leaving the AI sector for healthcare. Which stocks are on the upside?
Load more